// App-Quantinova.ai

BSH19‐PO‐152 : A Survey of UK Myeloma treating centres on thrombosis risk assessment and thromboprophylaxis practice in patients with Multiple Myeloma

Researchers

Presenter

  • R. Oliver

Principal Investigators

  • C. Bygrave

  • G. Cook

  • G. Jackson

  • C. Bradbury

Medical Centers

  • Oncology, Bristol Haematology and Oncology Centre, Bristol, UK

  • Rheumatology, University Hospital of Wales, Cardiff, UK

  • Hematology, Leeds Teaching Hospital

  • Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Multiple Myeloma

  • Venous thrombosis

Biomarkers

  • T cell receptor alpha locus

Drug/Treatment

  • apixaban

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved